AXA PPP enhances prostate cancer diagnosis pathway
One in eight men diagnosed
Screening which avoids needle insertion into prostate gland also used to detect skin or breast cancer
AXA PPP healthcare has teamed up with screening service, Check4Cancer, to enhance its prostate cancer diagnosis pathway. Available to its individual, SME and large corporate members, the new approach avoids the invasive routine of taking small samples of tissues for analysis via needle insertion into the prostate gland through the wall of the rectum, which misses cancer 50% of the time and can often lead to infection. Prostate cancer is the most common cancer in men and, according to Prostate...
More on PMI
AMII chair praises health insurance sector
For ‘standing up to task’
Machine learning social media platform launched to advertise life insurance
‘Positive time to advertise insurance’
Customer Care Awards goes virtual and shortlist announced!
Online ceremony on 15 July
L&G introduces digital trust process
Insurer adds digital approach to allow its existing customers to place their policies in trust
COVER attracts more than 200,000 hits during lockdown
Almost 1.2 million visits in a year
